Univeristy of Nebraska-Lincoln (UNL) scientist Ana Maria Vélez is pioneering a genetic treatment to contain western corn rootworm. The research seeks to contain agricultural pests by targeting ...

A new RNA type, smOOPs, has been found to drive biomolecular condensate formation in early development, offering new insight ...

Renaissance BioScience’s novel RNA production and delivery technology receives Mexican patent: Vancouver, Canada Monday, December 8, 2025, 17:00 Hrs [IST] Renaissance BioScience ...

RNA technology has had its own Big Bang event. It occurred just a couple of years ago when, seemingly out of nothing, the mRNA-based COVID-19 vaccines appeared. Well, they only seemed to come out of ...

This work was supported by funding from New Zealand Ministry of Business Innovation and Employment, Research Trust of Victoria University of Wellington and The Hugh Green Foundation. The recent award ...

Penn Commons at the University of Pennsylvania (Mark Henninger/Imagic Digital) Cellular-level biology that could help develop vaccines just got more accessible to researchers, thanks to AI. The ...

New solutions to previously uncontrolled pests, improved application efficicacy and climate resilience are all benefits Ryan Rapp, CEO and co-founder of Terrana Biosciences, says are possible. The ...

The global RNA therapeutics and vaccines market size was valued at USD 0.21 billion in 2024 and is predicted to hit around ...

Now, scientists have published incredible findings from a Siberian mammoth they've named Yuka, revealing that they've found mostly intact RNA that can be dated to around 40,000 years old. It's an ...

The Allan Labor Government is supporting Melbourne researchers who have discovered a groundbreaking RNA treatment targeting rare childhood diseases ...

PRQR, last year, failed a pivotal trial. This is the third time it has failed trials after showing early signs of efficacy. While they are making an effort, I see little future here. PRQR is a Dutch ...

Molecular Instruments, Inc. announced today that the Unified Patent Court (UPC) of the European Union has found that Molecular Instruments' HCR (TM) RNA-ISH technology does not infringe two patents ...